IL160143A0 - Novel imidazopyridine compounds with therapeutic effect - Google Patents
Novel imidazopyridine compounds with therapeutic effectInfo
- Publication number
- IL160143A0 IL160143A0 IL16014302A IL16014302A IL160143A0 IL 160143 A0 IL160143 A0 IL 160143A0 IL 16014302 A IL16014302 A IL 16014302A IL 16014302 A IL16014302 A IL 16014302A IL 160143 A0 IL160143 A0 IL 160143A0
- Authority
- IL
- Israel
- Prior art keywords
- therapeutic effect
- imidazopyridine compounds
- novel imidazopyridine
- novel
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE0102808A SE0102808D0 (sv) | 2001-08-22 | 2001-08-22 | New compounds |
| PCT/SE2002/001489 WO2003018582A1 (en) | 2001-08-22 | 2002-08-21 | Novel imidazopyridine compounds with therapeutic effect |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL160143A0 true IL160143A0 (en) | 2004-06-20 |
Family
ID=20285105
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL16014302A IL160143A0 (en) | 2001-08-22 | 2002-08-21 | Novel imidazopyridine compounds with therapeutic effect |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US20040220209A1 (xx) |
| EP (1) | EP1421083A1 (xx) |
| JP (1) | JP2005501870A (xx) |
| KR (1) | KR20040036723A (xx) |
| CN (1) | CN100343252C (xx) |
| AR (1) | AR035465A1 (xx) |
| BR (1) | BR0211846A (xx) |
| CA (1) | CA2456350A1 (xx) |
| HU (1) | HUP0401350A3 (xx) |
| IL (1) | IL160143A0 (xx) |
| IS (1) | IS7159A (xx) |
| MX (1) | MXPA04001402A (xx) |
| NO (1) | NO20040760L (xx) |
| NZ (1) | NZ531110A (xx) |
| PL (1) | PL367971A1 (xx) |
| RU (1) | RU2294935C2 (xx) |
| SE (1) | SE0102808D0 (xx) |
| WO (1) | WO2003018582A1 (xx) |
| ZA (1) | ZA200401114B (xx) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE0301904D0 (sv) | 2003-06-26 | 2003-06-26 | Astrazeneca Ab | Novel imidazopyridine compound II with therapeutic effect |
| KR20060099524A (ko) | 2003-11-03 | 2006-09-19 | 아스트라제네카 아베 | 무증상 위식도 역류의 치료를 위한 이미다조[1,2-ａ]피리딘유도체 |
| US20080033006A1 (en) * | 2004-01-26 | 2008-02-07 | Altana Pharma Ag | 1,2,4-Triazolo[ 1,5-A] Pyridines as Gastric Acid Secretion Inhibitors |
| US20090291977A1 (en) * | 2004-12-17 | 2009-11-26 | Madoka Jinno | Chromane Derivatives Useful As Acid Pump Antagonists |
| GB0513423D0 (en) * | 2005-06-30 | 2005-08-03 | Glaxo Group Ltd | Novel compounds |
| CA2645007A1 (en) * | 2006-03-17 | 2007-09-27 | Raqualia Pharma Inc. | Chromane derivatives |
| WO2008059373A1 (en) * | 2006-11-17 | 2008-05-22 | Raqualia Pharma Inc. | Imidazo [1, 2-a] pyrazine derivatives and their use as acid pump antagonists |
| KR200449743Y1 (ko) * | 2008-03-11 | 2010-08-05 | 주식회사 보루네오가구 | 파티션용 상부 스크린의 고정구조 |
| FI20086158A0 (fi) | 2008-12-03 | 2008-12-03 | Mikael Dahlstroem | Imidatsopyridiinijohdannaiset |
| BRPI1013288A2 (pt) | 2009-07-09 | 2016-03-29 | Raqualia Pharma Inc | uso de um composto, método de composição farmacêutica para o tratamento de doenças em que a motilidade gastrointestinal anormal está envolvida, kit e embalagem comercial que compreende uma composição farmacêutica contendo o composto |
| MX2012003469A (es) * | 2009-09-24 | 2012-04-19 | Hoffmann La Roche | Derivados de imidazopiridina o imidazopirimidina como inhibidores fosfodiesterasa 10a. |
| FR2962437B1 (fr) | 2010-07-06 | 2012-08-17 | Sanofi Aventis | Derives d'imidazopyridine, leur procede de preparation et leur application en therapeutique |
| TR201807602T4 (tr) * | 2013-01-31 | 2018-06-21 | Neomed Inst | İmidazopiridin bileşikleri ve bunların kullanımları. |
| JP2016520047A (ja) * | 2013-04-30 | 2016-07-11 | エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ | ピラゾールアミドのＰｄ触媒カップリング |
| CN106279151A (zh) * | 2015-06-26 | 2017-01-04 | 江苏太瑞生诺生物医药科技有限公司 | 5-(2-(8-((2,6-二甲基苄基)氨基)-2,3-二甲基咪唑并[1,2-a]吡啶-6-甲酰胺基)乙氧基)-5-氧代戊酸的固体形式及其制备方法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA81219B (en) * | 1980-01-23 | 1982-01-27 | Schering Corp | Imidazo (1,2-a) pyridines ,process for their preparation and pharmaceutical compositions containing them |
| EP0068378B1 (en) * | 1981-06-26 | 1986-03-05 | Schering Corporation | Novel imidazo(1,2-a)pyridines and pyrazines, processes for their preparation and pharmaceutical compositions containing them |
| US4725601A (en) * | 1985-06-04 | 1988-02-16 | Fujisawa Pharmaceutical Co., Ltd. | Certain imidazo[1,2-a]pyridines useful in the treatment of ulcers |
| EP0228006A1 (en) * | 1985-12-16 | 1987-07-08 | Fujisawa Pharmaceutical Co., Ltd. | Imidazopyridine compounds and processes for preparation thereof |
| SE9801526D0 (sv) * | 1998-04-29 | 1998-04-29 | Astra Ab | New compounds |
| SE9802794D0 (sv) * | 1998-08-21 | 1998-08-21 | Astra Ab | New compounds |
-
2001
- 2001-08-22 SE SE0102808A patent/SE0102808D0/xx unknown
-
2002
- 2002-08-09 AR ARP020103019A patent/AR035465A1/es not_active Application Discontinuation
- 2002-08-21 MX MXPA04001402A patent/MXPA04001402A/es unknown
- 2002-08-21 PL PL02367971A patent/PL367971A1/xx not_active Application Discontinuation
- 2002-08-21 CN CNB028160177A patent/CN100343252C/zh not_active Expired - Fee Related
- 2002-08-21 WO PCT/SE2002/001489 patent/WO2003018582A1/en active IP Right Grant
- 2002-08-21 NZ NZ531110A patent/NZ531110A/en unknown
- 2002-08-21 RU RU2004103628/04A patent/RU2294935C2/ru not_active IP Right Cessation
- 2002-08-21 IL IL16014302A patent/IL160143A0/xx unknown
- 2002-08-21 CA CA002456350A patent/CA2456350A1/en not_active Abandoned
- 2002-08-21 US US10/487,149 patent/US20040220209A1/en not_active Abandoned
- 2002-08-21 JP JP2003523243A patent/JP2005501870A/ja active Pending
- 2002-08-21 BR BR0211846-7A patent/BR0211846A/pt not_active IP Right Cessation
- 2002-08-21 HU HU0401350A patent/HUP0401350A3/hu unknown
- 2002-08-21 KR KR10-2004-7002466A patent/KR20040036723A/ko not_active Application Discontinuation
- 2002-08-21 EP EP02759036A patent/EP1421083A1/en not_active Withdrawn
-
2004
- 2004-02-11 ZA ZA200401114A patent/ZA200401114B/en unknown
- 2004-02-20 IS IS7159A patent/IS7159A/is unknown
- 2004-02-20 NO NO20040760A patent/NO20040760L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| SE0102808D0 (sv) | 2001-08-22 |
| PL367971A1 (en) | 2005-03-07 |
| NO20040760L (no) | 2004-02-20 |
| CN1543464A (zh) | 2004-11-03 |
| RU2004103628A (ru) | 2005-06-27 |
| JP2005501870A (ja) | 2005-01-20 |
| HUP0401350A2 (hu) | 2004-12-28 |
| HUP0401350A3 (en) | 2009-03-02 |
| IS7159A (is) | 2004-02-20 |
| WO2003018582A1 (en) | 2003-03-06 |
| ZA200401114B (en) | 2005-06-22 |
| US20040220209A1 (en) | 2004-11-04 |
| MXPA04001402A (es) | 2004-05-27 |
| KR20040036723A (ko) | 2004-04-30 |
| EP1421083A1 (en) | 2004-05-26 |
| CA2456350A1 (en) | 2003-03-06 |
| CN100343252C (zh) | 2007-10-17 |
| RU2294935C2 (ru) | 2007-03-10 |
| BR0211846A (pt) | 2004-09-08 |
| NZ531110A (en) | 2005-10-28 |
| AR035465A1 (es) | 2004-05-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL157642A0 (en) | Pyrazolopyrimidines as therapeutic agents | |
| IL157640A0 (en) | Pyrazolopyrimidines as therapeutic agents | |
| EP1463438A4 (en) | ENDOMURAL THERAPY | |
| IL156595A0 (en) | Therapeutic heterocyclic compounds | |
| IL160143A0 (en) | Novel imidazopyridine compounds with therapeutic effect | |
| GB0118383D0 (en) | Therapeutic methods | |
| GB0323258D0 (en) | Therapeutic compounds | |
| HU0103986D0 (en) | New compounds with therapeutic effect | |
| AU2003215150A8 (en) | Therapeutic compounds | |
| GB0101933D0 (en) | Therapy | |
| IL172530A0 (en) | Novel imidazopyridine compound ii with therapeutic effect | |
| GB0124710D0 (en) | Therapeutic composition | |
| GB0208392D0 (en) | Therapeutic compounds | |
| GB0128122D0 (en) | Therapeutic use | |
| GB0123991D0 (en) | New therapeutic use | |
| GB0100599D0 (en) | Therapeutic compounds | |
| GB0101636D0 (en) | Therapeutic compounds | |
| SI1641793T1 (sl) | Nova imidazopiridinska spojina II s terapevtskim učinkom | |
| GB0128089D0 (en) | Therapeutic use | |
| GB0128123D0 (en) | Therapeutic use | |
| GB0106802D0 (en) | Therapeutic use | |
| GB0128088D0 (en) | Therapeutic use | |
| GB0128128D0 (en) | Therapeutic use | |
| GB0128121D0 (en) | Therapeutic use | |
| GB0128126D0 (en) | Therapeutic use |